Tag
#eli lilly
Deals
Lilly to buy three vaccine developers in deal worth $3.8bn
Lilly said it will buy Curevo, LimmaTech and The Vaccine Company in deals worth up to $3.8 billion, widening its vaccine push through three smaller acquisitions.
By Naomi Voss
Banking
Eli Lilly prices $9bn eight-tranche bond, biggest-ever sale to fund $13bn M&A push
Eli Lilly priced $9bn of investment-grade bonds across eight tranches on Wednesday, its largest-ever debt sale, to fund the Centessa and Kelonia acquisitions. The 40-year tranche tightened 33 basis points from initial price talk to 80bp over Treasuries.
By Naomi Voss
